Mumbai: At the recently held, DIA IT Life Sciences Summit 2012, a host of current topics were discussed at length among ...
Singapore: Breaking its silence for the first time in 10 days after Indian drug major Ranbaxy's $500 million settlement ...
India's Council of Scientific and Industrial Research (CSIR) celebrated 70 years of existence this year. An organization...
Dr Yusuf K Hamied, CMD of India's largest pharma company, Cipla, has earned many unflattering epithets for building a co...
The drug discovery outsourcing market will experience high revenue growth from 2013-to-2023. Expansion of the market wil...
Bangalore: "India stands one among the top 10 league of countries in the Global Innovation Efficiency Index which shows ...
Singapore: India based Private equity (PE) major Actis Capital is said to be considering a sale of Ahmedabad-based Sterl...
With the suspension of the registration of 36 similar bio-therapeutic products in Sri Lanka, the country's healthcare ma...
Growing on its legacy of 127 years, Dabur India clocked $847 million in 2012. The company is recognized for manufactur...
A highly respected name in the Indian bioscience industry, Dr Raghunath Anant Mashelkar has been known for his critical ...
Bangalore: Temasek, a Singapore-based investment company with 11 affiliates and offices in Asia and Latin America, is lo...
Singapore: The Millennium Research Group (MRG) has estimated that Brazilian, Indian and Chinese markets for spinal impla...
Singapore: Held at Mumbai-based Jaslok hospital, Dr Sandra Desa Souza convened organized an international symposium on C...
Bangalore SRM University, which is located in the Indian state of Tamil Nadu, will establish a pharmaceutical company n...
Singapore: Ranbaxy received a rare distinction at the fourth Indian Affairs Business Leadership Awards 2013. The compan...
Singapore: Latest data released by the research firm AIOCD, revealed that the Indian domestic pharma retail market exper...
During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording ...
India's top drug regulatory body, the Central Drug Standard Control Organization (CDSO) is literally facing the heat, th...
